Shanghai Allist Pharmaceuticals Co., Ltd. (688578)

Profile

https://www.allist.com.cn

Shanghai Allist Pharmaceuticals Co., Ltd. is an innovative pharmaceutical company specialized in the research, development, production, and sales of oncology drugs. Focusing on the critical healthcare segment, Allist Pharmaceuticals is recognized for its commitment to providing effective treatment solutions for cancer, contributing significantly to the medical field. The company's product portfolio primarily targets various types of oncology treatments including small molecule drugs and biological products, addressing the pressing needs of cancer patients worldwide. As a participant in China's burgeoning pharmaceutical industry, Allist Pharmaceuticals plays a crucial role in improving healthcare outcomes and enhancing life quality. Listed on the Shanghai Stock Exchange under the STAR Market, the company aligns with China's strategic emphasis on advancing biotechnology and pharmaceuticals, propelling medical innovation and fostering new therapeutic possibilities. Engaged actively in domestic and international markets, it continuously invests in R&D to expand its scientific capabilities and drug offerings. Shanghai Allist Pharmaceuticals exemplifies a dedication to healthcare advancements and economic growth within the biotechnology sector.